Managers / Q3 2022 · view latest →
NJ State Employees Deferred Compensation Plan
CIK 0001483259 · 50 WEST STATE STREET 9TH FLOOR, PO BOX 290, TRENTON, NJ, 08625 · 609 292 5106
Summary
Nj State Employees Deferred Compensation Plan reported $584M in U.S.-listed holdings across 477 positions for Q3 2022.
Its largest position, AAPL, represents 6.6% of the portfolio.
Compared with Q2 2022, the fund opened 16 new positions and exited 16.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 94.8% · $553M
- REIT · 2.6% · $15M
- Other · 1.8% · $11M
- ADR · 0.4% · $2M
- Ltd Part · 0.4% · $2M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| SRPTSAREPTA THERAPEUTICS INC | NEW | +6.9K | 6.9K | +$763,000 | $763,000 |
| KARUNA THERAPEUTICS INC | NEW | +3.1K | 3.1K | +$697,000 | $697,000 |
| SPXCSPX TECHNOLOGIES INC | NEW | +12.0K | 12.0K | +$663,000 | $663,000 |
| SNYSANOFI | NEW | +13.0K | 13.0K | +$494,000 | $494,000 |
| REVANCE THERAPEUTICS INC | NEW | +17.9K | 17.9K | +$483,000 | $483,000 |
| VERVE THERAPEUTICS INC | NEW | +14.0K | 14.0K | +$481,000 | $481,000 |
| NTLAINTELLIA THERAPEUTICS INC | NEW | +7.1K | 7.1K | +$397,000 | $397,000 |
| COHRCOHERENT CORP | NEW | +11.0K | 11.0K | +$383,000 | $383,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2022
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $0 | 1 | Apr 23, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $0 | 1 | Jan 30, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $906M | 437 | Nov 7, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $846M | 437 | Aug 5, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $779M | 444 | May 9, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $823M | 462 | Feb 6, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $842M | 474 | Nov 4, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $804M | 473 | Aug 6, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $790M | 481 | May 2, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $727M | 484 | Feb 2, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $658M | 482 | Nov 8, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $693M | 487 | Aug 2, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $648M | 495 | Apr 26, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $618M | 483 | Jan 26, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $584M | 477 | Oct 28, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $614M | 477 | Aug 1, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $740M | 499 | May 2, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $795M | 503 | Jan 31, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $737M | 504 | Oct 26, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $752M | 516 | Jul 23, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $703M | 514 | Apr 26, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $648M | 504 | Feb 2, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $557M | 492 | Oct 27, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $532M | 500 | Aug 3, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $589M | 533 | Jan 31, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $547M | 533 | Oct 18, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $557M | 544 | Jul 24, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $550M | 538 | May 1, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $480M | 516 | Jan 24, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.